首页> 外文OA文献 >Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination

【2h】

Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination

机译：在感染变体或疫苗接种后感染后SARS-COV-2特异性IgG和病毒中和抗体的发展

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Franziska Neumann; Ruben Rose; Janine Römpke; Olaf Grobe; Thomas Lorentz; Helmut Fickenscher; Andi Krumbholz;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Performance of the Abbott SARS-CoV-2 IgG II Quantitative Antibody Assay Including the New Variants of Concern, VOC 202012/V1 (United Kingdom) and VOC 202012/V2 (South Africa), and First Steps towards Global Harmonization of COVID-19 Antibody Methods [J] . Emma English, Laura E. Cook, Isabelle Piec, Journal of Clinical Microbiology . 2021,第9期

机译：Abbott SARS-COV-2 IGG II的性能，包括关注的新变种，VOC 202012 / V1（英国）和VOC 202012 / V2（南非），以及全球协调Covid-19抗体的第一步方法
2. SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination [J] . Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, Cell Reports . 2021,第3期

机译：SARS-COV-2变体B.1.617是对Bamlanivimab的抵抗力，避免感染和疫苗接种诱导的抗体
3. mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection [J] . Stamatatos Leonidas, Czartoski Julie, Wan Yu-Hsin, Science . 2021,第6549期

机译：mRNA疫苗接种促进SARS-COV-2感染引发的交叉变体中和抗体
4. IgG SUBCLASS ANTIBODIES IN TRANSPLANT RECIPIENT SERA: AN IgG SUBCLASS SPECIFIC ASSAY TO DETERMINE THE "GOOD AND BAD" IgG IMMUNOGLOBULINS [C] . J Cicciarelli, N Kasahara, B. Pitpitan, Clinical Histocompatibility Workshop. . 2009

机译：移植受体血清中的IgG亚类抗体：一种IgG亚类特异性测定以确定“良好和坏”IgG免疫球蛋白
5. A novel approach to control and regulate the classical complement pathway: Highly specific inhibition of C1q globular head binding to human IgG using an engineered single chain antibody variable fragment; recruiting C1q to HER2 /neu positive cells using truncated bispecific antibodies [D] . Hwang, Hee Young 2007

机译：一种控制和调节经典补体途径的新方法：使用工程化的单链抗体可变片段高度特异性地抑制C1q球头与人IgG的结合；使用截短的双特异性抗体将C1q募集到HER2 / neu阳性细胞
6. Infection control occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data [O] . Annalee Yassi, Jennifer M. Grant, Karen Lockhart, 2021

机译：包括基于mRNA的疫苗接种对SARS-COV-2感染的感染控制保护医疗保健工人免受关注的变异：使用监控数据的14个月观测研究
7. Breadth of neutralising antibody responses to SARS-CoV-2 variants of concern is augmented by vaccination following prior infection: studies in UK healthcare workers and immunodeficient patients [O] . Angalee Nadesalingam, Diego Cantoni, David A Wells, 2021

机译：对SARS-COV-2对SARS-COV-2变体的抗体反应的宽度通过疫苗接种来增强：在英国医疗保健工人和免疫缺陷患者中的研究

Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination

著录项

引文网络

相似文献

相关主题

期刊订阅